Global Long-acting Recombinant Human Erythropoietin Injections Supply, Demand and Key Producers, 2024-2030
Page: 91
Published Date: 06 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Long-acting Recombinant Human Erythropoietin Injections market size is expected to reach $ 1234.2 million by 2030, rising at a market growth of 5.2% CAGR during the forecast period (2024-2030).
The market for long-acting recombinant human erythropoietin injections is a vital biopharmaceutical product used primarily in the treatment of anemia, particularly associated with kidney disease and anemia resulting from chemotherapy in leukemia. The market is substantial and continues to grow, benefitting from the ongoing expansion of global healthcare systems and the persistent demand for anemia treatments. In the future, with the continued advancement of biotechnology and increasing therapeutic needs, long-acting recombinant human erythropoietin injections are poised for further development, potentially involving broader application areas and improved therapeutic solutions to offer more effective anemia management for patients.
Long-acting erythropoietin (EPO) drugs are a type of medication used to stimulate the production of red blood cells in the body. These drugs are primarily prescribed for individuals with certain medical conditions, such as anemia associated with chronic kidney disease or cancer treatment.
This report studies the global Long-acting Recombinant Human Erythropoietin Injections production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Long-acting Recombinant Human Erythropoietin Injections, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting Recombinant Human Erythropoietin Injections that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Long-acting Recombinant Human Erythropoietin Injections total production and demand, 2019-2030, (K Units)
Global Long-acting Recombinant Human Erythropoietin Injections total production value, 2019-2030, (USD Million)
Global Long-acting Recombinant Human Erythropoietin Injections production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Recombinant Human Erythropoietin Injections consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Long-acting Recombinant Human Erythropoietin Injections domestic production, consumption, key domestic manufacturers and share
Global Long-acting Recombinant Human Erythropoietin Injections production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Long-acting Recombinant Human Erythropoietin Injections production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Long-acting Recombinant Human Erythropoietin Injections production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Long-acting Recombinant Human Erythropoietin Injections market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson and Kyowa Kirin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting Recombinant Human Erythropoietin Injections market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Long-acting Recombinant Human Erythropoietin Injections Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Long-acting Recombinant Human Erythropoietin Injections Market, Segmentation by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Global Long-acting Recombinant Human Erythropoietin Injections Market, Segmentation by Application
Anemia
Kidney Disorders
Others
Companies Profiled:
Amgen
Johnson & Johnson
Kyowa Kirin
Key Questions Answered
1. How big is the global Long-acting Recombinant Human Erythropoietin Injections market?
2. What is the demand of the global Long-acting Recombinant Human Erythropoietin Injections market?
3. What is the year over year growth of the global Long-acting Recombinant Human Erythropoietin Injections market?
4. What is the production and production value of the global Long-acting Recombinant Human Erythropoietin Injections market?
5. Who are the key producers in the global Long-acting Recombinant Human Erythropoietin Injections market?
Table of Contents
1 Supply Summary
1.1 Long-acting Recombinant Human Erythropoietin Injections Introduction
1.2 World Long-acting Recombinant Human Erythropoietin Injections Supply & Forecast
1.2.1 World Long-acting Recombinant Human Erythropoietin Injections Production Value (2019 & 2023 & 2030)
1.2.2 World Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030)
1.2.3 World Long-acting Recombinant Human Erythropoietin Injections Pricing Trends (2019-2030)
1.3 World Long-acting Recombinant Human Erythropoietin Injections Production by Region (Based on Production Site)
1.3.1 World Long-acting Recombinant Human Erythropoietin Injections Production Value by Region (2019-2030)
1.3.2 World Long-acting Recombinant Human Erythropoietin Injections Production by Region (2019-2030)
1.3.3 World Long-acting Recombinant Human Erythropoietin Injections Average Price by Region (2019-2030)
1.3.4 North America Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030)
1.3.5 Europe Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030)
1.3.6 China Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030)
1.3.7 Japan Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Long-acting Recombinant Human Erythropoietin Injections Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Long-acting Recombinant Human Erythropoietin Injections Major Market Trends
2.1 World Long-acting Recombinant Human Erythropoietin Injections Demand (2019-2030)
2.2 World Long-acting Recombinant Human Erythropoietin Injections Consumption by Region
2.2.1 World Long-acting Recombinant Human Erythropoietin Injections Consumption by Region (2019-2024)
2.2.2 World Long-acting Recombinant Human Erythropoietin Injections Consumption Forecast by Region (2025-2030)
2.3 United States Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.4 China Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.5 Europe Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.6 Japan Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.7 South Korea Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.8 ASEAN Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
2.9 India Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030)
3.1 World Long-acting Recombinant Human Erythropoietin Injections Production Value by Manufacturer (2019-2024)
3.2 World Long-acting Recombinant Human Erythropoietin Injections Production by Manufacturer (2019-2024)
3.3 World Long-acting Recombinant Human Erythropoietin Injections Average Price by Manufacturer (2019-2024)
3.4 Long-acting Recombinant Human Erythropoietin Injections Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Long-acting Recombinant Human Erythropoietin Injections Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Long-acting Recombinant Human Erythropoietin Injections in 2023
3.5.3 Global Concentration Ratios (CR8) for Long-acting Recombinant Human Erythropoietin Injections in 2023
3.6 Long-acting Recombinant Human Erythropoietin Injections Market: Overall Company Footprint Analysis
3.6.1 Long-acting Recombinant Human Erythropoietin Injections Market: Region Footprint
3.6.2 Long-acting Recombinant Human Erythropoietin Injections Market: Company Product Type Footprint
3.6.3 Long-acting Recombinant Human Erythropoietin Injections Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Value Comparison
4.1.1 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Comparison
4.2.1 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Consumption Comparison
4.3.1 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Long-acting Recombinant Human Erythropoietin Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value (2019-2024)
4.4.3 United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024)
4.5 China Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers and Market Share
4.5.1 China Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value (2019-2024)
4.5.3 China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024)
4.6 Rest of World Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024)
5.1 World Long-acting Recombinant Human Erythropoietin Injections Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Epoetin-alfa
5.2.2 Epoetin-beta
5.2.3 Darbepoetin-alfa
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Long-acting Recombinant Human Erythropoietin Injections Production by Type (2019-2030)
5.3.2 World Long-acting Recombinant Human Erythropoietin Injections Production Value by Type (2019-2030)
5.3.3 World Long-acting Recombinant Human Erythropoietin Injections Average Price by Type (2019-2030)
6.1 World Long-acting Recombinant Human Erythropoietin Injections Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Anemia
6.2.2 Kidney Disorders
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Long-acting Recombinant Human Erythropoietin Injections Production by Application (2019-2030)
6.3.2 World Long-acting Recombinant Human Erythropoietin Injections Production Value by Application (2019-2030)
6.3.3 World Long-acting Recombinant Human Erythropoietin Injections Average Price by Application (2019-2030)
7.1 Amgen
7.1.1 Amgen Details
7.1.2 Amgen Major Business
7.1.3 Amgen Long-acting Recombinant Human Erythropoietin Injections Product and Services
7.1.4 Amgen Long-acting Recombinant Human Erythropoietin Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Amgen Recent Developments/Updates
7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Product and Services
7.2.4 Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Kyowa Kirin
7.3.1 Kyowa Kirin Details
7.3.2 Kyowa Kirin Major Business
7.3.3 Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Product and Services
7.3.4 Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Kyowa Kirin Recent Developments/Updates
7.3.6 Kyowa Kirin Competitive Strengths & Weaknesses
8.1 Long-acting Recombinant Human Erythropoietin Injections Industry Chain
8.2 Long-acting Recombinant Human Erythropoietin Injections Upstream Analysis
8.2.1 Long-acting Recombinant Human Erythropoietin Injections Core Raw Materials
8.2.2 Main Manufacturers of Long-acting Recombinant Human Erythropoietin Injections Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Long-acting Recombinant Human Erythropoietin Injections Production Mode
8.6 Long-acting Recombinant Human Erythropoietin Injections Procurement Model
8.7 Long-acting Recombinant Human Erythropoietin Injections Industry Sales Model and Sales Channels
8.7.1 Long-acting Recombinant Human Erythropoietin Injections Sales Model
8.7.2 Long-acting Recombinant Human Erythropoietin Injections Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Region (2019-2024) & (USD Million)
Table 3. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Region (2025-2030) & (USD Million)
Table 4. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Region (2019-2024)
Table 5. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Region (2025-2030)
Table 6. World Long-acting Recombinant Human Erythropoietin Injections Production by Region (2019-2024) & (K Units)
Table 7. World Long-acting Recombinant Human Erythropoietin Injections Production by Region (2025-2030) & (K Units)
Table 8. World Long-acting Recombinant Human Erythropoietin Injections Production Market Share by Region (2019-2024)
Table 9. World Long-acting Recombinant Human Erythropoietin Injections Production Market Share by Region (2025-2030)
Table 10. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Long-acting Recombinant Human Erythropoietin Injections Major Market Trends
Table 13. World Long-acting Recombinant Human Erythropoietin Injections Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Long-acting Recombinant Human Erythropoietin Injections Consumption by Region (2019-2024) & (K Units)
Table 15. World Long-acting Recombinant Human Erythropoietin Injections Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Long-acting Recombinant Human Erythropoietin Injections Producers in 2023
Table 18. World Long-acting Recombinant Human Erythropoietin Injections Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Long-acting Recombinant Human Erythropoietin Injections Producers in 2023
Table 20. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Long-acting Recombinant Human Erythropoietin Injections Company Evaluation Quadrant
Table 22. World Long-acting Recombinant Human Erythropoietin Injections Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Long-acting Recombinant Human Erythropoietin Injections Production Site of Key Manufacturer
Table 24. Long-acting Recombinant Human Erythropoietin Injections Market: Company Product Type Footprint
Table 25. Long-acting Recombinant Human Erythropoietin Injections Market: Company Product Application Footprint
Table 26. Long-acting Recombinant Human Erythropoietin Injections Competitive Factors
Table 27. Long-acting Recombinant Human Erythropoietin Injections New Entrant and Capacity Expansion Plans
Table 28. Long-acting Recombinant Human Erythropoietin Injections Mergers & Acquisitions Activity
Table 29. United States VS China Long-acting Recombinant Human Erythropoietin Injections Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Long-acting Recombinant Human Erythropoietin Injections Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Long-acting Recombinant Human Erythropoietin Injections Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share (2019-2024)
Table 37. China Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share (2019-2024)
Table 42. Rest of World Based Long-acting Recombinant Human Erythropoietin Injections Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share (2019-2024)
Table 47. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Long-acting Recombinant Human Erythropoietin Injections Production by Type (2019-2024) & (K Units)
Table 49. World Long-acting Recombinant Human Erythropoietin Injections Production by Type (2025-2030) & (K Units)
Table 50. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Type (2019-2024) & (USD Million)
Table 51. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Type (2025-2030) & (USD Million)
Table 52. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Long-acting Recombinant Human Erythropoietin Injections Production by Application (2019-2024) & (K Units)
Table 56. World Long-acting Recombinant Human Erythropoietin Injections Production by Application (2025-2030) & (K Units)
Table 57. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Application (2019-2024) & (USD Million)
Table 58. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Application (2025-2030) & (USD Million)
Table 59. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Long-acting Recombinant Human Erythropoietin Injections Product and Services
Table 64. Amgen Long-acting Recombinant Human Erythropoietin Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Product and Services
Table 70. Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 73. Kyowa Kirin Major Business
Table 74. Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Product and Services
Table 75. Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 76. Global Key Players of Long-acting Recombinant Human Erythropoietin Injections Upstream (Raw Materials)
Table 77. Long-acting Recombinant Human Erythropoietin Injections Typical Customers
Table 78. Long-acting Recombinant Human Erythropoietin Injections Typical Distributors
List of Figure
Figure 1. Long-acting Recombinant Human Erythropoietin Injections Picture
Figure 2. World Long-acting Recombinant Human Erythropoietin Injections Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Long-acting Recombinant Human Erythropoietin Injections Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030) & (K Units)
Figure 5. World Long-acting Recombinant Human Erythropoietin Injections Average Price (2019-2030) & (US$/Unit)
Figure 6. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Region (2019-2030)
Figure 7. World Long-acting Recombinant Human Erythropoietin Injections Production Market Share by Region (2019-2030)
Figure 8. North America Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030) & (K Units)
Figure 9. Europe Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030) & (K Units)
Figure 10. China Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030) & (K Units)
Figure 11. Japan Long-acting Recombinant Human Erythropoietin Injections Production (2019-2030) & (K Units)
Figure 12. Long-acting Recombinant Human Erythropoietin Injections Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 15. World Long-acting Recombinant Human Erythropoietin Injections Consumption Market Share by Region (2019-2030)
Figure 16. United States Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 17. China Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 18. Europe Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 19. Japan Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 20. South Korea Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 22. India Long-acting Recombinant Human Erythropoietin Injections Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Long-acting Recombinant Human Erythropoietin Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting Recombinant Human Erythropoietin Injections Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting Recombinant Human Erythropoietin Injections Markets in 2023
Figure 26. United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Long-acting Recombinant Human Erythropoietin Injections Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Long-acting Recombinant Human Erythropoietin Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share 2023
Figure 30. China Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Long-acting Recombinant Human Erythropoietin Injections Production Market Share 2023
Figure 32. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Type in 2023
Figure 34. Epoetin-alfa
Figure 35. Epoetin-beta
Figure 36. Darbepoetin-alfa
Figure 37. Others
Figure 38. World Long-acting Recombinant Human Erythropoietin Injections Production Market Share by Type (2019-2030)
Figure 39. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Type (2019-2030)
Figure 40. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Long-acting Recombinant Human Erythropoietin Injections Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Application in 2023
Figure 43. Anemia
Figure 44. Kidney Disorders
Figure 45. Others
Figure 46. World Long-acting Recombinant Human Erythropoietin Injections Production Market Share by Application (2019-2030)
Figure 47. World Long-acting Recombinant Human Erythropoietin Injections Production Value Market Share by Application (2019-2030)
Figure 48. World Long-acting Recombinant Human Erythropoietin Injections Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Long-acting Recombinant Human Erythropoietin Injections Industry Chain
Figure 50. Long-acting Recombinant Human Erythropoietin Injections Procurement Model
Figure 51. Long-acting Recombinant Human Erythropoietin Injections Sales Model
Figure 52. Long-acting Recombinant Human Erythropoietin Injections Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amgen Johnson & Johnson Kyowa Kirin
Related Reports
21 Oct 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
